Finance

Lists
IGC:NYSEAMERICAN
IGC Pharma Inc
0,27 USD
+1,81%
(+0,0049) 1D
0,27 USD
-1,53% (-0,0042)
After hours
Closed: 2-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IGC...
Open
0,28 USD
High
0,28 USD
Low
0,27 USD
Mkt. cap
28,42 млн
Avg. vol.
740,22 миң
Volume
629,69 миң
52-wk high
0,45 USD
52-wk low
0,24 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
103,38 млн
No. of employees
70
Open
0,28 USD
High
0,28 USD
Low
0,27 USD
Mkt. cap
28,42 млн
Avg. vol.
740,22 миң
Volume
629,69 миң
52-wk high
0,45 USD
52-wk low
0,24 USD
EPS
-0,08 USD
Beta
0,47
Shares outstanding
103,38 млн
No. of employees
70
News stories
From web sources and news partners
About IGC Pharma Inc
CEO-
Employees70
Founded2005
HeadquartersПотомак, Мэриленд, Америка Кошмо Штаттары
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2024-ж. дек.
2025-ж. мар.
2026-ж. мар.
2026-ж. июн.
Revenue
257,00 миң
330,00 миң
317,00 миң
265,00 миң
Cost of goods sold
153,00 миң
176,00 миң
174,00 миң
217,00 миң
Cost of revenue
153,00 миң
176,00 миң
262,00 миң
217,00 миң
Research and development expenses
852,00 миң
997,00 миң
1,27 млн
1,59 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,13 млн
619,00 миң
1,20 млн
1,41 млн
Operating expense
1,98 млн
1,62 млн
2,51 млн
2,83 млн
Total operating expenses
2,14 млн
1,79 млн
2,78 млн
3,05 млн
Operating income
-1,88 млн
-1,46 млн
-2,46 млн
-2,78 млн
Other non operating income
49,00 миң
190,00 миң
56,00 миң
1,08 млн
EBT including unusual items
-1,83 млн
-1,20 млн
-1,60 млн
-2,94 млн
EBT excluding unusual items
-1,83 млн
-1,27 млн
-1,60 млн
-2,94 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,83 млн
-1,20 млн
-2,40 млн
-1,82 млн
Net profit margin
-711,67%
-362,73%
-757,73%
-1 107,92%
Earnings per share
-0,02
-0,01
-0,02
-0,03
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,72 млн
-1,31 млн
-2,40 млн
-2,73 млн
Gain or loss from assets sale
-
-25,00 миң
-
-
AI content may include mistakes. Learn more
Google колдонмолору